Business
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment - Nature

What the report says
Six proteomic clocks are applied in a clinical trial to assess anti-aging effects.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Drought effect on regional milk industry as Kenya turns to UgandaThe Independent Uganda
The 25 years we were never taught to liveThe Observer
Why Uganda wants private money to help transform farmingThe Observer